We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA TO ADDRESS CLINICAL DATA IN NEW GUIDANCE
FDA TO ADDRESS CLINICAL DATA IN NEW GUIDANCE
September 9, 2004
The FDA is on the verge of releasing a new guidance document that addresses the use of computerized systems in clinical trials, a move that could help the agency establish a consistent, risk-based approach to Part 11 for all segments of the pharmaceutical industry.